BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11224487)

  • 1. Sequential fluorescence in situ hybridization analyses for trisomy 12 in chronic leukemic B-cell disorders.
    Hjalmar V; Hast R; Kimby E
    Haematologica; 2001 Feb; 86(2):174-80. PubMed ID: 11224487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
    Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
    Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trisomy 12 and lymphoplasmacytoid lymphocytes in chronic leukemic B-cell disorders.
    Hjalmar V; Kimby E; Matutes E; Sundström C; Jacobsson B; Arvidsson I; Hast R
    Haematologica; 1998 Jul; 83(7):602-9. PubMed ID: 9718864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential fluorescence in situ hybridization analysis for trisomy 12 in B-cell chronic lymphocytic leukemia.
    Hjalmar V
    Methods Mol Med; 2005; 115():231-40. PubMed ID: 15998971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The interphase fluorescence in situ hybridization (I-FISH) technique in patients with chronic lymphatic leukemia (CLL)].
    Michalová K; Zemanová Z; Cmunt E; Karban J; Brezinová J; Sindelárová L; Kurková S; Kubcová S; Schwarz J
    Cas Lek Cesk; 2000 Jun; 139(11):334-8. PubMed ID: 10953412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, biological, and immunophenotypical characteristics of B-cell chronic lymphocytic leukemia with trisomy 12 by fluorescence in situ hybridization.
    Tabernero MD; San Miguel JF; Garcia JL; Garcia-Isidoro M; Wiegant J; Ciudad J; Gonzalez M; Rios A; Raap A; Orfao A
    Cytometry; 1995 Sep; 22(3):217-22. PubMed ID: 8556953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
    Lindhagen E; Norberg M; Kanduri M; Tobin G; Säisänen L; Aberg M; Gustafsson MG; Sundström C; Rosenquist R; Aleskog A
    Eur J Haematol; 2009 Jul; 83(1):22-34. PubMed ID: 19245531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 13q14 deletions are not primary events in B-cell chronic lymphocytic leukemia: a study of 100 patients using fluorescence in situ hybridization.
    Avet-Loiseau H; Devilder MC; Garand R; Bouyge I; Rapp MJ; Milpied N; Harousseau JL; Moisan JP; Bataille R
    Clin Cancer Res; 1996 Oct; 2(10):1673-7. PubMed ID: 9816115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of chromosomal abnormalities in chronic lymphocytic leukemia increased by interphase fluorescence in situ hybridization in tetradecanoylphorbol acetate-stimulated peripheral blood cells.
    Sánchez J; Aventín A
    Cancer Genet Cytogenet; 2007 May; 175(1):57-60. PubMed ID: 17498559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of chromosome alterations detected by FISH in Turkish patients with B-cell chronic lymphocytic leukemia.
    Durak B; Akay OM; Aslan V; Ozdemir M; Sahin F; Artan S; Gülbas Z
    Cancer Genet Cytogenet; 2009 Jan; 188(2):65-9. PubMed ID: 19100507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trisomy 8 in B-cell chronic lymphocytic leukemia.
    Pozdnyakova O; Stachurski D; Hutchinson L; Ramakrishnan S; Miron PM
    Cancer Genet Cytogenet; 2008 May; 183(1):49-52. PubMed ID: 18474297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of cytogenetic results in B-cell chronic lymphocytic leukemia using immuno-purified leukemic cells.
    Brizard A; Brizard F; Lessard M; Dreyfus B; Guilhot F; Tanzer J
    Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):103-5. PubMed ID: 8511032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
    Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
    Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of chromosomal abnormalities associated with chronic lymphocytic leukemia: what is the best method?
    El-Taweel M; Barin C; Cymbalista F; Eclache V
    Cancer Genet Cytogenet; 2009 Nov; 195(1):37-42. PubMed ID: 19837267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular cytogenetic characteristics of chronic lymphocytic leukemia].
    Xu W; Li JY; Pan JL; Qiu HR; Shen YF; Xiao B; Chen LJ; Wu YF; Sheng RL; Xue YQ
    Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):349-52. PubMed ID: 17044998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mosaicism of trisomy 12 in chronic lymphocytic leukemia detected by non-radioactive in situ hybridization.
    Raghoebier S; Kibbelaar RE; Kleiverda JK; Kluin-Nelemans JC; van Krieken JH; Kok F; Kluin PM
    Leukemia; 1992 Nov; 6(11):1220-6. PubMed ID: 1434807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of chromosomal anomalies detected with FISH and their clinical correlations in B-chronic lymphocytic leukemia.
    Sindelárová L; Michalová K; Zemanová Z; Ransdorfová S; Brezinová J; Peková S; Schwarz J; Karban J; Cmunt E
    Cancer Genet Cytogenet; 2005 Jul; 160(1):27-34. PubMed ID: 15949567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of different chromosomal aberrations on molecular cytogenetic parameters in chronic lymphocytic leukemia.
    Amiel A; Leopold L; Gronich N; Yukla M; Fejgin MD; Lishner M
    Cancer Genet Cytogenet; 2006 Jun; 167(2):145-9. PubMed ID: 16737914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion of cells with trisomy 12 associated with progressive lymphocytosis and a dramatic change in chimera status in a patient with chronic lymphocytic leukemia.
    Esparza C; Romero A; Méndez R; Serrano A; Jurado M; Jiménez P; Ruiz-Cabello F
    Haematologica; 2002 Jul; 87(7):ECR25. PubMed ID: 12091140
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.
    Mittal AK; Hegde GV; Aoun P; Bociek RG; Dave BJ; Joshi AD; Sanger WG; Weisenburger DD; Joshi SS
    Int J Mol Med; 2007 Oct; 20(4):461-9. PubMed ID: 17786276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.